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aBstraCt
According to the latest reports Demodex mites appear to play an important role in the pathogenesis of chronic ble-
pharitis. Demodex mites are cosmopolitan and are present in many species of mammals. In this paper we describe two 
species that are found in humans: Demodex folliculorum and D. brevis. Infection occurs during direct contact with an 
affected person and also through contact with dust containing eggs of the parasite, through contact with bed linen, 
as well as cosmetics used together with an affected person. Treatment of chronic blepharitis caused by D. folliculorum 
and D. brevis is difficult and time consuming. Some improvement can be achieved after topical application of yellow 
mercury ointment, sulphuric ointment, camphor oil, crotamiton, cholinesterase inhibitors, sulfacetamide, steroids, 
antibiotics and antifungal drugs. Good results have been achieved with oral ivermectin and permethrin cream.  
However, the best results were observed after treatment with metronidazole.
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introduCtion
Blepharitis can be caused by bacterial or fungal 
infection, allergic reaction, metabolic disease, uncor-
rected refractive errors, and Demodex spp. Anterior 
blepharitis is usually caused by staphylococcal infec-
tion, while posterior blepharitis is usually related to 
meibomian gland dysfunction or seborrheic blepha-
roconjunctivitis. Recent reports have highlighted 
the importance of Demodex mites in the patho-
genesis of chronic blepharitis, especially in cases 
with weak reaction to treatment. Recurrent horde-
ola and chalazia can be a result of Demodex spp. 
infection [1].
Demodex mites are cosmopolitan and are there-
fore found in different species of mammals. At the 
time of writing, two species have been found in 
humans: Demodex brevis (Akbulatova, 1963) and 
D. folliculorum (Simon, 1842). Recently these two 
species have been classified as parasites after previous-
ly being described as commensals [2]. However, the 
pathogenicity of these two species of mites is con-
troversial because they can also be found in healthy 
individuals [3]. Based on the results of current stud-
ies, it is estimated that Demodex mites are present in 
10% of healthy people and can be found in 12% of 
their hair follicles [4]. It is postulated that D. fol-
li culorum becomes pathogenic when it reproduces 
intensively, causing increasing ocular symptoms [5].
BioLogiCaL properties
Demodex mites have a vermiform shape and are 
covered by a thin cuticle (Fig. 1). Demodex fol-
liculorum are larger (0.3–0.4 mm) and are more 
elongated. They live in larger groups in the orifices 
of hair follicles. Demodex brevis is smaller (0.2– 
–0.3 mm) and has a fusiform shape and short legs. It 
can be found in single sebaceous glands throughout 
the facial skin and also in the meibomian glands 
of the eyelids [6]. The body of Demodex mites can 
be divided into the gnathosoma with the mouth-
part, the podosome, and the opisthosoma. In both 




Figure 1. Developmental stages of Demodex folliculorum: a — egg; B–d — adults (magnification 100×)
species the podosome has four pairs of legs and three 
pairs in larvae. The gnathosoma of D. folliculorum 
contains sharp and more dagger-like mandibles than 
in D. brevis, which serve to take up food, and palps 
that are necessary to hold food. The mandibles serve 
to cut the epithelium of the hosts skin. The parasites 
excrete enzymes that can initially digest food, after 
which the mites suck it in. This form of feeding causes 
the destruction of the epithelium and the penetration 
of the parasite into the deeper layers of the skin. The 
main food source in all stages of development are the 
components of serum. As a result, the parasites thrive 
in areas that are especially rich in sebaceous glands 
[7–8]. The life cycle of D. folliculorum lasts between 
14 and 18 days. The development is simple and it 
occurs in only one host. The female lays eggs, from 
which larvae initially without legs hatch. The larvae 
then develop three pairs of unsegmented legs. Af-
ter the first moulting, the larvae transform into an 
eight-legged nymph, and after another two moultings 
into an adult form, either female or male [9].
Demodex spp. is sensitive to changes in temper-
ature and pH. The optimal temperature for the de-
velopment of Demodex spp. ranges from 16 to 20°C. 
The parasites stop feeding at temperatures below 
0°C or above 37°C. At temperatures above 54–58°C 
they die. Demodex mites prefer an acidic environ-
ment and are sensitive to UV radiation [10–11].
epideMioLogY
Demodex folliculorum and D. brevis most of-
ten occur in elderly patients. Cheng et al. [12] 
found a prevalence rate of 84% in a population 
aged 60 years and almost 100% in a population 
over 70 years old. Garbacewicz et al. [13] noted 
a low prevalence in young people (5%), which 
can probably be attributed to excretion of smaller 
amounts of sebum by the sebaceous glands of 
Zeiss and the Meibomian tarsal glands in children 
and teenagers [11].
Infection occurs through direct contact with an 
affected person and most likely through contact 
with dust containing eggs of the parasite, through 
contact with bed linen, or by sharing the same cos-
metics with an affected person [14–15]. Moreover, 
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it has been discovered that eggs of Demodex spp. 
can be found in microscope eyepieces. The results 
of studies carried out by Garbacewicz et al. [13] 
showed that 30% of people using a microscope were 
infected with Demodex spp.
The factors having an influence on Demodex spp. 
infection are profession, type of skin, dermatological 
illnesses, living standards, housing and work place 
standards, as well as personal hygiene habits [8]. 
Wesołowska et al. [16] found that Demodex spp. 
occurs in 40% of people of a medical profession 
such as doctors, nurses, and physiotherapists, and 
in 33.7% of medical students and 23.5% of drug 
abusers. Ocular demodicosis can be a result of the 
presence of mites on the facial skin [17–18]. Demo-
dex spp. infection has been observed in 47% of peo-
ple with oily skin, in 26.6% of people with dry skin, 
and in 33.9% of people with a mixed complexion. 
People with dermatological illnesses such as rosacea 
and skin acne are more susceptible to Demodex spp. 
infection (62%) than healthy people (27.6%). 
A higher infection rate has been also observed in pa-
tients living in areas of humid climate (67.9%) than 
in people living in areas of dry climate (24.5%) [19]. 
Wesołowska et al. [16] described a higher prevalence 
of Demodex spp. infection among people living in 
older housing (43.5%) than among people living 
in newer housing (39.4%). However, the difference 
was not statistically significant. 
Some researchers have described the prevalence 
of Demodex spp. infection to be related to the sex of 
the examined patients. Raszeja-Kotelba et al. [20] 
and Forton et al. [21] have given a higher intensity 
of infection in women than in men, which was at-
tributed to the use of creams and powders as well as 
being influenced by sex hormones. However, Hor-
váth et al. [22] observed that the infection rate was 
higher in men than in women. Yamashita et al. [23] 
and Kuźna-Grygiel et al. [14] as well as Wesołows-
ka et al. [16] did not find a relationship between 
sex and the prevalence of Demodex spp. infection. 
Dokuyucu et al. [24] examined the correlation of 
D. folliculorum infection and the body mass index 
(BMI). The results indicated that increased BMI in-
fluenced the prevalence of Demodex spp. infection. 
26.3% of overweight or obese patients (BMI > 35) 
had D. folliculorum. A higher prevalence was also 
found in underweight patients (13.3%). However, 
Gökҫe et al. [25] did not find any relationship be-
tween the prevalence of D. folliculorum and BMI. 
It has also been observed that Demodex spp. occurs 
more often in patients with lower immunity [26, 27]. 
Demodex spp. infection has been noted in patients 
with HIV, leukaemia, or cancer [28, 29]. Demodex spp. 
has been diagnosed in patients with diabetes, renal 
failure, and in patients undergoing haemodialysis 
[3, 25, 28, 30]. 
There are publications proving a relationship be-
tween Demodex spp. infection and blepharitis. Tian 
and Chao-Pin [31] examined 507 patients with 
blepharitis and noted that 50.7% of patients have 
Demodex spp. The authors also observed Demodex 
spp. in 58 patients (11.7%) with other eye dis-
eases. Türk et al. [32] observed D. folliculorum in 
29.7% of patients with blepharitis, in 9.1% of pa-
tients with blepharoconjunctivitis, and in 4.2% of 
patients in a control group. Bhandari and Reddy [5] 
discovered the mites in 78.7% of people with 
chronic blepharitis. However, Kemal et al. [33] did 
not observe any statistically significant difference of 
the prevalence of Demodex spp. in patients with and 
without blepharitis. Wesołowska et al. [16] similarly 
did not observe any higher prevalence of demodi-
cosis in people wearing eyeglasses or contact lenses.
pathogenesis
Demodex mites feed on the cells lining hair 
follicles. Metabolites and undigested leftovers can 
accumulate at the base of eyelashes and create cy-
lindrical dandruff, which is pathognomonic for oc-
ular demodicosis [12]. Demodex spp. mechanically 
block sebaceous glands, irritate the eyelids, and in-
duce hypertrophy of the epithelium and hyperkera-
tinisation. Demodex spp. may induce in the host 
a granulomatous inflammation and immunologic 
response [34–35]. Köksal et al. [36] have observed 
a granuloma within a Meibomian gland harbouring 
Demodex spp. and surrounded by epithelial cells, 
stromal cells, fibroblasts, lymphocytes, and plasmat-
ic cells. In studies carried out by Liang et al. [37] 
demodicosis was found along with chalazia 69.2% 
more often than in the control group (20.3%). 
Additionally, patients with demodicosis had a ten-
dency to relapse (33.3%), especially those infected 
with D. brevis, which is more often found than 
D. folliculorum in patients with chalazia.
Yam et al. [38] discovered Demodex mites in 
72.9% of patients with recurrent chalazia. They 
concluded that recurrent chalazia is associated with 
ocular demodicosis.
Past studies have shown that in the aqueous 
humour of patients infected with Demodex spp. 
there is more interleukin 17 (IL-17), which causes 
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inflammation and blockage of the glands. In addi-
tion, it can cause damage to the eye surface [39–40]. 
Akilov and Mumcuoglu [41] have shown that in 
people with demodicosis, the level of CD95+ is 
elevated, while CD3+, CD4+, CD8+, CD16+, and 
the CD3+/CD20+ ratio is lower. No difference in 
the concentrations of IgA, IgM, and IgG has been 
found. Kim et al. [39] examined the clinical and 
immunological response to Demodex spp. infection. 
A significant decrease in IL-1b and IL-17 was ob-
served in patients receiving treatment. The level 
of IL-5, IL-7, IL-12, IL-13, G–CSF, and MIP-1b 
also decreased; however, the difference was not sta-
tistically significant. Demodex mites can avoid or 
suppress the immunological response of the host 
by inhibiting all three pathways of the complement 
system (classical, lectin and alternative) through sca-
bies mite-inactivated serine protease paralogues and 
serine protease inhibitors [29]. 
sYMptoMs
The clinical symptoms of ocular demodicosis are 
uncharacteristic and patients are frequently asymp-
tomatic. Gao et al. [42] noted a correlation between 
the number of Demodex mites and the intensity 
of symptoms. Patients with blepharitis and diag-
nosed presence of Demodex mites have complained 
of symptoms such as: itchiness, a burning sensation, 
a feeling of heavy eyelids, excessive lacrimation, 
and the presence of mucous discharge [5]. Other 
symptoms of ocular demodicosis may include eye-
lid and conjunctival hyperaemia, madarosis, loss 
of eyebrows, photophobia, and excessive sensitiv-
ity to smoke and dust [11]. Gao et al. [42] noted 
Meibomian gland dysfunction in 63.6% and loss 
of eyelashes in 45.5% of people with diagnosed 
eyelid demodicosis. Kheirkhah et al. [43] observed 
meibomian gland dysfunction in 83.3%, rosacea 
in 66.7%, and decreased vision in 50% of patients 
with blepharitis caused by Demodex mites. Inceboz 
et al. [44] observed itchiness (61.7%) and hyperae-
mia (59.1%) in patients with D. folliculorum.
Untreated ocular demodicosis may lead to serious 
complications. Inflammation caused by a large num-
ber of parasites and serious symptoms of blephar-
itis may affect the cornea, conjunctiva, and cause 
neovascularisation, conjunctival hyperaemia, and 
conjunctiva of nipple follicles [8]. Patients treated 
using antibiotics or antiviral drugs may note a short 
improvement and decrease in symptoms. However, 
a delay in providing appropriate treatment may ulti-
mately lead to corneal ulceration, corneal clouding, 
or the formation of white spots, which have a signi-
ficant influence on visual acuity [8].
deModeX spp. as a VeCtor
It has been established that Demodex mites take 
part in the transmission of pathogens, which may 
play a prominent role in the pathogenesis of demod-
icosis [45]. Symptomatic demodicosis often coexists 
with bacterial infections, which can be confirmed 
by the decreasing number of Demodex mites after 
the treatment of patients with acne using tetracy-
clines [46]. Spickett [47] noted that D. folliculorum 
may be a vector organism for Mycobacterium leprae 
bacilli. Lacey et al. [48] isolated Bacillus oleronius 
from within the D. folliculorum of a patient of acne 
rosacea and specific antigens from the serum of 
examined patients. Similar results were reported 
by Szkaradkiewicz et al. [49]. They described both 
Demodex spp. and B. oleronius in patients with acute 
blepharitis. Clifford et al. [50] noted the coexist-
ence of Staphylococcus aureus and D. folliculorum 
in patients with diabetes; however, such a situation 
was not described by Lee et al. [51]. Demodex spp. 
can take part in the transmission of fungi [52]. 
Hallur et al. [53] described a coinfection of D. folli-
culorum and Apophysomyces elegant in patients with 
decreased resistance.
diagnosis
In the diagnosis of ocular demodicosis, eyelashes 
are examined — a few are taken aseptically from 
both eyelids of both eyes. The material is examined 
under a light microscope at 100× magnification. It 
can be also examined in saline at 25× magnification. 
If cylindrical dandruff is present, 20 µL of 100% 
alcohol or a 0.25% solution of fluorescein drops 
should be pipetted into the edge of the coverslip 
to enable the migration of the parasite. The time 
of examination extends to 20 minutes [17]. In the 
case of recurrent chalazia, the lesions can be taken 
for histopathological examination to determine the 
presence of Demodex mites [8].
treatMent
Treatment of chronic blepharitis caused by D. fol - 
liculorum and D. brevis is difficult and time con-
suming. Some improvement can be achieved after 
topical application of yellow mercury ointment, 
sulphuric ointment, camphor oil, crotamiton, cho-
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linesterase inhibitors, sulfacetamide, steroids, antibi-
otics, and antifungal drugs. Good results have been 
achieved with simultaneous oral ivermectin and per-
methrin cream [54–55]. Filho et al. [56] examined 
the effectiveness of oral ivermectin in patients with 
blepharitis with proven Demodex spp. infestation. 
Complete resolution was achieved 90 days after in-
itiation of treatment independently of the intensity 
of the infection. Brown et al. [57] noted the case of 
a 12-year-old girl with serious ocular demodicosis 
and rosacea, who improved a month after receiving 
single-dose 12-mg therapy with ivermectin.
However, we obtained the best results after treat-
ment with metronidazole. Therefore, we encourage 
the use of the following ointments:
•	 Metronidazoli — 0.5;
•	 Glycerini — 2.0;
•	 Vaselini albi ad — 20.0;
•	 M. f. unq. ophthalmicum;
•	 S — twice daily on eyelid margins;
and:
•	 Metronidazoli — 3.0;
•	 Hascobaza — 100.0;
•	 M. f. unq.;
•	 S — twice daily on face.
The treatment of ocular demodicosis takes be-
tween two and three months. Subsequently we 
check whether the parasite is still present. If De-
modex spp. can still be found, then the treatment is 
continued for another 2–3 months [58].
A prepared formula of Spanish sage oil and ly-
ophilised aloe is available on the market. Special 
handkerchiefs and solutions can be used in main-
taining eyelid hygiene. The symptoms of ocular de-
modicosis can be alleviated by sunbathing, washing 
the skin of the face with a mixture of warm water 
and hexachlorobenzene. 
The prophylaxis of Demodex spp. infection con-
sists of rigorous eyelid care, improvement of per-
sonal hygiene, and not sharing towels and cosmetics 
with people infected with Demodex spp.
However, the role of Demodex spp. as a commensal 
should not be overlooked. Treatment should not be 
aimed at total eradication of the mite but rather res-
toration of the ocular ecology to a balanced state [59].
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